Skip to content

SupporTive Care At Home Research for Patients With Advanced Cancer (STAHR-cancer)

SupporTive Care At Home Research (STAHR): a Cluster Non-randomized Controlled Trial for Patients With Advanced Cancer

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05636384
Acronym
HOMECARE
Enrollment
396
Registered
2022-12-05
Start date
2022-07-25
Completion date
2026-12-31
Last updated
2022-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Home Care Services, Malignant Neoplasm, Quality of LIfe, Unplanned Hospitalization

Brief summary

To test the effects of home-based care on unplanned hospitalization within 6 months among advanced cancer patients with decreased performance status. Home-based care includes education for patients and their family caregivers, home visits by specialized home-based medical staff, and regular status check-ups.

Detailed description

This study is a cluster, non-randomized controlled trial to test the effects of home-based care on unplanned hospitalization in 6 months among advanced cancer patients with decreased performance status. Home-based care includes education for patients and their family caregivers, home visits by specialized home-based medical staff, and regular status check-up. We are recruiting the study participants from 6 institutions, aiming for 396 cancer patients. Participants for the intervention group will be recruited from Seoul National University Hospital, Chung-ang University Hospital, and Dongguk University Ilsan Hospital. Participants for the control group will be recruited from Kyung Hee University Medical Center, CHA Bundang Medical Center, and Seoul National University Bundang Hospital.

Interventions

OTHERHome-based care

Home-based medical care is based on a specialized home-based medical team approach, including following: 1. Specialized Home-Based Medical Team Approach 2. Initial Assessment and Education 3. Initial Home Visits and Education 4. Multidisciplinary Team Meeting 5. Regular Assessment After the Initial Visit

Sponsors

Chung-Ang University Hosptial, Chung-Ang University College of Medicine
CollaboratorOTHER
DongGuk University
CollaboratorOTHER
Kyung Hee University Hospital
CollaboratorOTHER
Bundang CHA Hospital
CollaboratorOTHER
Seoul National University Bundang Hospital
CollaboratorOTHER
Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

A cluster, non-randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Both the patient and their family caregiver must meet the criteria to be considered for this research. 1. Patient 1. A person who has an advanced-stage solid cancer diagnosis (ICD-10 code C00-C70); A person who is receiving or planning to receive cancer treatment 2. A person who meets one of the following conditions 1. Has been evaluated as having ECOG performance status 2 2. Has been evaluated as having ECOG performance status 1 and is over 70 years of age 3. A person who wishes to stay at home 4. A person whose family caregiver resides at home 5. A person who wishes to participate in the research 2. Family Caregiver 1. A family\* member of the patient \* Family: refers to the patient's spouse (including a common-law partner), descendants and their spouses up to the second degree, siblings and their spouses, and relatives and their spouses up to the eighth degree. 2. A person who meets one of the following conditions: 1. Lives with the patient (patient's household member) 2. Does not live with the patient, but visits the patient's home more than three times a week 3. A person who wants the patient to stay at home 4. A person who can communicate easily with medical staff 5. A person who wishes to participate in the research

Exclusion criteria

If either the patient or the family caregiver meets any one of these criteria, they are excluded from the study. 1. Patient 1. A person who cannot speak, hear, or read Korean 2. A person who is judged by a medical doctor to be unable to take part in this research due to extremely poor health 3. A person residing outside the range that can be visited by the respective medical institution (the conditions for distance are to be specified by each medical institution)\* \* This condition is not applicable for the control group. 4. A person who has used hospital- or home-type hospice and palliative care services 5. A person who is under the age of 19 2. Family Caregiver 1. A person who cannot speak, hear, or read Korean 2. A person who is judged by a medical doctor to be unable to take part in this research due to extremely poor health 3. A person under the age of 19

Design outcomes

Primary

MeasureTime frameDescription
Unplanned hospitalizationwithin 6 months following enrollment1. admission to the enrolled hospital to treat unexpected symptoms or medical conditions (not including planned admission for chemotherapy or admission for planned surgery or intervention) 2. admission to a hospital other than the enrolled hospital 3. admission to a nursing hospital for a duration of less than 4 weeks.

Secondary

MeasureTime frameDescription
Quality of life of patient - ESASwithin 6 months following enrollmentModified Edmonton Symptom Assessment System (ESAS) of patient
Quality of life of patient - EQ-5Dwithin 6 months following enrollmentEuro-Quality of Life-5 Dimension (EQ-5D) of patient
Depressive symptom of patientwithin 6 months following enrollmentPatient Health Questionnaire-9 (PHQ-9) of patient
Patient medical utilizationwithin 6 months following enrollmentThe total number of hospital utilization, including hospitalization, emergency room visit, and clinic visits
Hospitalizationwithin 6 months following enrollmentthe number of hospitalization
ER visitswithin 6 months following enrollmentthe number of emergency room visits
Healthcare usewithin 6 months following enrollmentthe number of healthcare use for severe diseases
Patient end-of-life care: ICU admissionwithin 1 month before deathICU admission one month before death
Patient end-of-life care: an advance directivewithin 1 month before deathCompletion of advance medical directives within 1 month before death
Satisfaction with services (patient)within 6 months following enrollmentSatisfaction of the study participant (patient) with the service in this study, evaluated by questionnaire
Quality of life of family caregiverwithin 6 months following enrollmentEuro-Quality of Life-5 Dimension (EQ-5D) of family caregiver
Care burden of family caregiverwithin 6 months following enrollmentThe Korean version of Caregiver Reaction Assessment (CRA-K) of family caregiver
Depressive symptom of family caregiverwithin 6 months following enrollmentPatient Health Questionnaire-9 (PHQ-9) of family caregiver
Caring competency of family caregiverwithin 6 months following enrollmentCaring competency of family caregiver, measured by questionnaire
Satisfaction with services (family caregiver)within 6 months following enrollmentSatisfaction of the study participant (family caregiver) with the service in this study, evaluated by questionnaire
Expenseswithin 6 months following enrollmentmedical expenses, care expenses
Patient end-of-life care: ventilator treatmentwithin 1 month before deathMechanical ventilator apply one month before death

Countries

South Korea

Contacts

Primary ContactGa-Young Lee
yoyo4284@snu.ac.kr82-10-6527-3066
Backup ContactSo-Hee Kim
sh6487@snu.ac.kr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026